Cargando…

The role of pharmacists in deprescribing benzodiazepines: A scoping review

BACKGROUND: Polypharmacy can increase the risk of adverse drug events, hospitalisation, and unnecessary healthcare costs. Evidence indicates that discontinuing certain medications, such as benzodiazepines, can improve health outcomes, by resolving adverse drug effects. This scoping review aims to ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashkanani, Fatemah Zakariya, Rathbone, Adam Pattison, Lindsey, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511800/ https://www.ncbi.nlm.nih.gov/pubmed/37743854 http://dx.doi.org/10.1016/j.rcsop.2023.100328

Ejemplares similares

Lifting lockdown COVID19 restrictions: What can pharmacists do as the world wakes up?
por: Ashkanani, Fatemah, et al.
Publicado: (2021)

Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
por: Pollmann, André S., et al.
Publicado: (2015)

Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review
por: Wang, Yanning, et al.
Publicado: (2023)

Practices and Perceptions of Community Pharmacists in the Management of Atopic Dermatitis: A Systematic Review and Thematic Synthesis
por: Cayci, Abdi Berk, et al.
Publicado: (2023)

Barriers and enablers to pharmacists' involvement in a novel immunisation programme
por: Rathbone, Adam Pattison, et al.
Publicado: (2022)

A systematic review and thematic synthesis to identify factors that influence pharmacists' involvement in asthma care services: An identity crisis
por: Taqi, Amnah, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
por: Niznik, Joshua D., et al.
Publicado: (2022)

Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative
por: Carr, Frances, et al.
Publicado: (2019)

Implementation of an Opioid and Benzodiazepine Deprescribing Program for Older Adults in an Outpatient Setting
por: Armistead, Lori, et al.
Publicado: (2020)

Student Perspectives on the Pharmacist’s Role in Deprescribing Opioids: A Qualitative Study
por: Cernasev, Alina, et al.
Publicado: (2023)

A Need for Benzodiazepine Deprescribing in the COVID-19 Pandemic: A Cohort Study
por: Bužančić, Iva, et al.
Publicado: (2022)

Deprescribing practices in Canada: A scoping review
por: Desai, Mansi, et al.
Publicado: (2022)

Exploration of Barriers and Facilitators for Deprescribing Opioids and Benzodiazepines to Reduce Older Adult Falls
por: Roberts, Ellen, et al.
Publicado: (2020)

“I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing
por: Springer, Sydney P., et al.
Publicado: (2022)

The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review
por: Rasmussen, Anja Fog, et al.
Publicado: (2021)

Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study
por: Sibille, François-Xavier, et al.
Publicado: (2022)

Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists
por: Lukacena, Kaylee M., et al.
Publicado: (2022)

Implementation of pharmacist-led deprescribing in collaborative primary care settings
por: Trenaman, Shanna C., et al.
Publicado: (2022)

Evaluation of the effectiveness of a joint general practitioner-pharmacist intervention on the implementation of benzodiazepine deprescribing in older adults (BESTOPH-MG trial): protocol for a cluster-randomized controlled trial
por: Huon, Jean-François, et al.
Publicado: (2023)

Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups
por: Evrard, Perrine, et al.
Publicado: (2023)

A pharmacist-led medication review service with a deprescribing focus guided by implementation science
por: Alaa Eddine, Nada, et al.
Publicado: (2023)

Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study
por: Clark, Collin M., et al.
Publicado: (2020)

Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study
por: Gerlach, Navina, et al.
Publicado: (2020)

Effectiveness of pharmacist intervention for deprescribing potentially inappropriate medications: a prospective observational study
por: Kimura, Takeshi, et al.
Publicado: (2022)

The impact of in hospital patient-education intervention on older people’s attitudes and intention to have their benzodiazepines deprescribed: a feasibility study
por: Gnjidic, Danijela, et al.
Publicado: (2019)

Does COVID-19 change dietary habits and lifestyle behaviours in Kuwait: a community-based cross-sectional study
por: Husain, Wafaa, et al.
Publicado: (2020)

Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices
por: Alves, Ana, et al.
Publicado: (2019)

Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework
por: Evrard, Perrine, et al.
Publicado: (2022)

CONSIDERATIONS OF AGE-FRIENDLY 4M PRINCIPLES IN DEPRESCRIBING INTERVENTIONS: A SCOPING REVIEW
por: Wang, Jinjiao, et al.
Publicado: (2022)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists
por: Scott, Sion, et al.
Publicado: (2020)

Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural Veterans
por: Bhardwaj, Sonia, et al.
Publicado: (2022)

Deprescribing as an Opportunity to Facilitate Patient-Centered Care: A Qualitative Study of General Practitioners and Pharmacists in Japan
por: Ie, Kenya, et al.
Publicado: (2023)

Peripartum mental health and the role of the pharmacist: A scoping review
por: Urslak, Randilynne, et al.
Publicado: (2023)

Role of pharmacist in the management of Hansen's Disease: A scoping review
por: de Oliveira Duarte, Elza Cristina, et al.
Publicado: (2023)

Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: A scoping review
por: Oktora, M. P., et al.
Publicado: (2020)

Deprescribing intervention activities mapped to guiding principles for use in general practice: a scoping review
por: Coe, Amy, et al.
Publicado: (2021)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Role of pharmacist during the COVID-19 pandemic: A scoping review
por: Visacri, Marília Berlofa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h27e7hkct6qsfchi1glni7neup